Rohit Kulkarni, Roth MKM managing director, joins 'Squawk on the Street' to discuss how the ban of TikTok impacts the social ...

Internet & Capital Markets Analyst Kulkarni, along with Feifan Wang, Founder of SourceMedium, highlight 4Q trends and 2025 advertising ...

Roth MKM downgraded Reddit (RDDT) to Neutral from Buy with a price target of $195, up from $116. The firm is raising its estimates and target, ...

Fintel reports that on January 21, 2025, Roth MKM initiated coverage of Synergy CHC (NasdaqCM:SNYR) with a Buy recommendation. What is the Fund Sentiment? There are 2 funds or institutions reporting ...

Replimune Group Inc (REPL) stock saw a modest uptick, ending the day at $11.85 which represents a slight increase of $1.71 or 16.86% from the prior close of $10.14. The stock opened at $12.6 and ...

Coterra Energy Inc (CTRA) stock saw a decline, ending the day at $29.15 which represents a decrease of $-0.32 or -1.09% from the prior close of $29.47. The stock opened at $29.04 and touched a low of ...

Roth MKM keeps a Buy rating on Imax (IMAX) with a $28 price target after the company signed an exclusive, worldwide deal with ...

Roth MKM lowered the firm’s price target on Mattel (MAT) to $20 from $21 and keeps a Neutral rating on the shares ahead of ...

Roth Mkm started coverage on shares of Reviva Pharmaceuticals (NASDAQ:RVPH – Free Report) in a report released on Friday,Benzinga reports. The brokerage issued a buy rating and a $7.00 price target on ...

Roth Mkm started coverage on shares of Verona Pharma (NASDAQ:VRNA – Free Report) in a report released on Friday morning, MarketBeat.com reports. The firm issued a buy rating and a $68.00 price ...

Friday - Shares of Verona Pharma (NASDAQ:VRNA) received a positive outlook from Roth/MKM as the firm initiated coverage with a Buy rating and a 12-month price target of $68. The bullish stance is ...